A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2011
03/22/2011	US7910594 Antiproliferative agents; gene overexpression
03/22/2011	US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
03/22/2011	US7910545 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
03/22/2011	US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression
03/22/2011	US7910132 Pharmaceutical composition for the treatment of acute disorders
03/22/2011	US7910115 Polypeptide absorbable into digestive organs
03/22/2011	US7910114 Methods of treating infectious diseases
03/22/2011	US7910104 Modified anti-CD52 antibody
03/22/2011	US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
03/22/2011	CA2492342C Novel bio-active pyrimidine derivatives
03/22/2011	CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/22/2011	CA2480880C Inhibitors of akt activity
03/22/2011	CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
03/22/2011	CA2478229C Pyridinoylpiperidines as 5-ht1f agonists
03/22/2011	CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
03/22/2011	CA2471769C Oral insulin therapy
03/22/2011	CA2471538C Pyrrolopyrimidines
03/22/2011	CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011	CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor
03/22/2011	CA2433675C Pharmaceutically active piperidine derivatives
03/22/2011	CA2433603C Kappa opioid receptor ligands
03/22/2011	CA2432572C Oxybenzamides derivatives as factor xa inhibitors
03/22/2011	CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/22/2011	CA2397294C Glyburide composition
03/22/2011	CA2396519C A process for isolation of osteopontin from milk
03/22/2011	CA2390166C Hedgehog fusion proteins and uses
03/22/2011	CA2382636C Fish feed with increased nucleotide content
03/22/2011	CA2379581C Echinacea supplement and method of manufacture
03/22/2011	CA2361590C Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
03/22/2011	CA2359334C Bifidobacterium in the treatment of inflammatory disease
03/22/2011	CA2335941C Treatment of hyperproliferative disorders
03/22/2011	CA2333965C Method of enhancing lysosomal .alpha.-galactosidase a
03/22/2011	CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea)
03/22/2011	CA2280949C Dextran derivatives, preparation method and applications as medicine with specific biological action
03/22/2011	CA2240409C Mammalian cx3c chemokine genes
03/17/2011	WO2011030929A1 Compound for inhibiting type 3 17β-hydroxysteroid dehydrogenase
03/17/2011	WO2011030927A1 Compound for inhibiting type-3 17β-hydroxysteroid dehydrogenase
03/17/2011	WO2011030892A1 Novel substrate peptide for rho-kinase
03/17/2011	WO2011030873A1 Benzyl compounds
03/17/2011	WO2011030872A1 Sulfonamide compounds
03/17/2011	WO2011030871A1 N-substituted heteroaryl compounds
03/17/2011	WO2011030868A1 Substituted carbonyl compounds
03/17/2011	WO2011030865A1 Substituted zenzyl compounds
03/17/2011	WO2011030864A1 Aniline compounds
03/17/2011	WO2011030847A1 Inducer composition for hematopoietic stem cells
03/17/2011	WO2011030798A1 8-oxodihydropurine derivative
03/17/2011	WO2011030774A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units
03/17/2011	WO2011030552A1 Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue
03/17/2011	WO2011030116A1 Use of steroid compounds for inflammatory and autoimmune disorders
03/17/2011	WO2011029996A1 Use of vap-1 inhibitors for treating fibrotic conditions
03/17/2011	WO2011029265A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
03/17/2011	US20110066182 Tissue Sealant for Use in Non Compressible Hemorrhage
03/17/2011	US20110065918 New phenylalanine derivatives
03/17/2011	US20110065809 Polymerization of Multifunctional Azides, and Polymers Therefrom
03/17/2011	US20110065799 Urokinase inhibitors, production and use thereof
03/17/2011	US20110065793 Highly purified ethyl epa and other epa derivatives
03/17/2011	US20110065780 Insulin resistance improving agent
03/17/2011	US20110065774 Chemically modified oligonucleotides and uses thereof
03/17/2011	US20110065773 Rna interference mediating small rna molecules
03/17/2011	US20110065770 Formulations comprising antisense nucleotides to connexins
03/17/2011	US20110065760 Compounds for the inhibition of rotamases and use thereof
03/17/2011	US20110065736 Quinazoline derivatives as vegf inhibitors
03/17/2011	US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/17/2011	US20110065697 2-oxy-benzoxazinone derivatives for the treatment of obesity
03/17/2011	US20110065693 Therapeutic pyrazoloquinoline derivatives
03/17/2011	US20110065665 Stabilization of vitamin b12
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110064822 Biomaterial and preparation method thereof
03/17/2011	US20110064791 Self forming, thermodynamically stable liposomes and their applications
03/17/2011	US20110064787 Detoxifying patch
03/17/2011	US20110064782 Methods and compositions for tissue regeneration
03/17/2011	US20110064780 Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064748 Pharmaceutical combination and method for treating tumor
03/17/2011	US20110064734 Prevention and treatment of amyloidogenic disease
03/17/2011	US20110064727 Immunoglobulin Variants Outside the Fc Region
03/17/2011	US20110064720 Dietary Supplement Compositions and Methods of Making and Using the Same
03/17/2011	US20110064709 Use of ecdi-fixed cell tolerance as a method for preventing allograft rejection
03/17/2011	US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064677 Lipoxin analogs and methods for the treatment of periodontal disease
03/17/2011	US20110064674 Luminescent multimodal nanoparticle probe system and method of manufacture thereof
03/17/2011	US20110064672 Articles and Compositions for Enhancing Sports Scores
03/17/2011	US20110064670 Method to identify a patient with an increased likelihood of responding to an anti-cancer agent
03/17/2011	US20110064666 Compound
03/17/2011	US20110064662 Kit for producing molecular probe for pet screening for drug discovery
03/17/2011	US20110064658 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
03/17/2011	US20110061651 Formoterol superfine formulation
03/17/2011	CA2774099A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
03/17/2011	CA2773997A1 Aniline compound
03/17/2011	CA2773600A1 Use of steroid compounds for inflammatory and autoimmune disorders
03/17/2011	CA2773590A1 8-oxodihydropurine derivative
03/17/2011	CA2773218A1 Use of vap-1 inhibitors for treating fibrotic conditions
03/17/2011	CA2772656A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units
03/16/2011	EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof
03/16/2011	EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use.
03/16/2011	EP2295541A1 Pluripotent stem cell derived from cardiac tissue
03/16/2011	EP2295540A1 Bioengineered tissue constructs and methods for producing and using them

1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 1564